196 related articles for article (PubMed ID: 1747926)
1. Glutathione S-transferase mu in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts.
Liu YH; Taylor J; Linko P; Lucier GW; Thompson CL
Carcinogenesis; 1991 Dec; 12(12):2269-75. PubMed ID: 1747926
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of model substrates or microsomally-activated aflatoxin B1 with reduced glutathione, catalysed by cytosolic glutathione-S-transferases in livers of rats, mice and guinea pigs.
Neal GE; Nielsch U; Judah DJ; Hulbert PB
Biochem Pharmacol; 1987 Dec; 36(24):4269-76. PubMed ID: 3120734
[TBL] [Abstract][Full Text] [Related]
3. Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1.
Quinn BA; Crane TL; Kocal TE; Best SJ; Cameron RG; Rushmore TH; Farber E; Hayes MA
Toxicol Appl Pharmacol; 1990 Sep; 105(3):351-63. PubMed ID: 2173169
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.
Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP
Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634
[TBL] [Abstract][Full Text] [Related]
5. The trans-stilbene oxide-active glutathione transferase in human mononuclear leucocytes is identical with the hepatic glutathione transferase mu.
Seidegård J; Guthenberg C; Pero RW; Mannervik B
Biochem J; 1987 Sep; 246(3):783-5. PubMed ID: 3689332
[TBL] [Abstract][Full Text] [Related]
6. Dietary restriction modulated carcinogen-DNA adduct formation and the carcinogen-induced DNA strand breaks.
Chou MW; Chen W; Mikhailova MV; Nichols J; Weis C; Jackson CD; Hart RW; Chung KT
Toxicol Lett; 1997 Jun; 92(1):21-30. PubMed ID: 9242354
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in rabbit lung and liver.
Stewart RK; Serabjit-Singh CJ; Massey TE
Toxicol Appl Pharmacol; 1996 Oct; 140(2):499-507. PubMed ID: 8887467
[TBL] [Abstract][Full Text] [Related]
8. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
Chou MW; Chen W
J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
[TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene metabolism and DNA adduct formation mediated by English sole liver enzymes.
Nishimoto M; Varanasi U
Biochem Pharmacol; 1985 Jan; 34(2):263-8. PubMed ID: 4038451
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of aflatoxin B1 in human lung.
Donnelly PJ; Stewart RK; Ali SL; Conlan AA; Reid KR; Petsikas D; Massey TE
Carcinogenesis; 1996 Nov; 17(11):2487-94. PubMed ID: 8968067
[TBL] [Abstract][Full Text] [Related]
11. Mouse liver glutathione S-transferase isoenzyme activity toward aflatoxin B1-8,9-epoxide and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide.
Ramsdell HS; Eaton DL
Toxicol Appl Pharmacol; 1990 Sep; 105(2):216-25. PubMed ID: 2120795
[TBL] [Abstract][Full Text] [Related]
12. The genetic variation and the expression of human glutathione transferase mu.
Seidegård J; Pero RW
Klin Wochenschr; 1988; 66 Suppl 11():125-6. PubMed ID: 3184770
[TBL] [Abstract][Full Text] [Related]
13. Epoxidation of aflatoxin B1 by Aspergillus flavus microsomes in vitro: interaction with DNA and formation of aflatoxin B1-glutathione conjugate.
Saxena M; Allameh A; Mukerji KG; Raj HG
Chem Biol Interact; 1991; 78(1):13-22. PubMed ID: 1901247
[TBL] [Abstract][Full Text] [Related]
14. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
[TBL] [Abstract][Full Text] [Related]
15. Effect of glucose administration on hamster liver S9-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and aflatoxin B1.
Rubano DC; Teel RW; Strother A
Cancer Lett; 1990 Jul; 52(2):123-31. PubMed ID: 2116220
[TBL] [Abstract][Full Text] [Related]
16. Glutathione transferase activities of cultured human lymphocytes.
Jones SM; Brooks BA; Langley SC; Idle JR; Hirom PC
Carcinogenesis; 1988 Mar; 9(3):395-8. PubMed ID: 3257909
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary restriction on glutathione S-transferase activity specific toward aflatoxin B1-8,9-epoxide.
Chen W; Nichols J; Zhou Y; Chung KT; Hart RW; Chou MW
Toxicol Lett; 1995 Aug; 78(3):235-43. PubMed ID: 7624894
[TBL] [Abstract][Full Text] [Related]
18. Human variability in hepatic glutathione S-transferase-mediated conjugation of aflatoxin B1-epoxide and other substrates.
Slone DH; Gallagher EP; Ramsdell HS; Rettie AE; Stapleton PL; Berlad LG; Eaton DL
Pharmacogenetics; 1995 Aug; 5(4):224-33. PubMed ID: 8528269
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism and excretion of benzo(a)pyrene in 2 species of ictalurid catfish.
Willett KL; Gardinali PR; Lienesch LA; Di Giulio RT
Toxicol Sci; 2000 Nov; 58(1):68-76. PubMed ID: 11053542
[TBL] [Abstract][Full Text] [Related]
20. Identification of the trans-stilbene oxide-active glutathione transferase in human mononuclear leukocytes and in liver as GST1.
Seidegård J; Pero RW; Stille B
Biochem Genet; 1989 Apr; 27(3-4):253-61. PubMed ID: 2775173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]